RSS Feed RSS Feed

Department: DEPARTMENT OF HEALTH AND HUMAN SERVICES

Browse: Departments   Dates   Agencies  

The Federal Register

Pages: 12

1. Statement of Organization, Functions, and Delegations of Authority

NOTICES: AIDS, STD and TB Laboratory Research Division,

Part C (Centers for Disease Control and Prevention) of the Statement of Organizations, Functions, and Delegations of Authority of the Department of Health and Human Services (45 FR 6777276, dated October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as amended most recently at 65 FR 68144, dated November 14, 2000) is amended to

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Centers for Disease Control and Prevention

2. Proposed Information Collection Activity; Comment Request

NOTICES: Proposed collection; comment request,

Proposed Projects

Title: Child Care CaseLevel Report.

OMB No.: 09700167.

Description: Section 658K of the Child Care and Development Block Grant Act of 1990 (Pub. L. 101508, 42 U.S.C. 9858) requires that States and Territories submit monthly caselevel data on the children and families receiving direct services under the Child Care and

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Children and Families Administration

3. New Animal Drugs for Use in Animal Feeds; Salinomycin and Bacitracin Methylene Disalicylate

RULES: Salinomycin, bacitracin methylene disalicylate,

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Alpharma, Inc. The NADA provides for use of approved, singleingredient salinomycin and bacitracin methylene disalicylate Type A medicated articles to make twoway combination drug Type C
DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

4. Indirect Food Additives: Paper and Paperboard Components

RULES: Paper and paperboard components—; 4-(diiodomethylsulfonyl) toluene,

The Food and Drug Administration (FDA) is amending the food additive regulations to provide for the safe use of 4
(diiodomethylsulfonyl) toluene as a slimicide in the manufacture of foodcontact paper and paperboard. This action is in response to a petition filed by Angus Chemical Co.
DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

5. Agency Information Collection Activities; Proposed Collection; Comment Request; Use of Impact-Resistant Lenses in

NOTICES: Proposed collection; comment request,

The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each
DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

6. Agency Information Collection Activities; Submission for OMB Review; Comment Request; Substances Approved for Use in

NOTICES: Submission for OMB review; comment request,

The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

7. [Docket Nos. 82F-0349, 90F-0188, 91F-0169, 93F-0157, 93F-0199, 95F- 0011, 96F-0032, 96F-0223, 98F-0226, 98F-0288,

NOTICES: Asahi Chemical Industry Co., Ltd., et al.; withdrawn,

The Food and Drug Administration (FDA) is announcing the withdrawal, without prejudice to a future filing, of 18 food additive petitions proposing that the food additive regulations be amended to provide for the safe use of certain new food additives. The petitioners subsequently requested that their petitions be converted to food contact
DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

8. 2001 National Antimicrobial Resistance Monitoring System (NARMS) Scientific Meeting; Public Meeting

NOTICES: 2001 National Antimicrobial Resistance Monitoring System Scientific Meeting,

The Food and Drug Administration (FDA) is announcing the following meeting entitled ``2001 NARMS Scientific Meeting.'' The topic to be discussed is the results from NARMS and related antimicrobial resistance research.
DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

9. Food Safety Risk Analysis Clearinghouse; Data Quality Objectives; Public Meeting

NOTICES: Food safety risk analysis clearinghouse; data quality issues,

The Food and Drug Administration (FDA) is announcing a public meeting cosponsored by the interagency Risk Assessment Consortium (RAC) and the Joint Institute for Food Safety and Applied Nutrition (JIFSAN). The purpose of this public meeting is to encourage discussion and gain input from the public and professionals on data quality issues as they
DEPARTMENT OF HEALTH AND HUMAN SERVICES : Food and Drug Administration

10. Public Health Service Standards for the Protection of Research Misconduct Whistleblowers

PROPOSED RULES: See Centers for Disease Control and Prevention; See Children and Families Administration; See Food and Drug Administration; See Health Care Financing Administration; See Health Resources and Services Administration; See National Institutes of Health; Protection of research misconduct whistleblowers; Public Health Service standards,

The Department proposes to add a new Subchapter I, Part 94, to Title 42 of the Code of Federal Regulations to implement section 493(e) of the Public Health Service Act. Under this proposed regulation, covered institutions must follow certain requirements for preventing or otherwise responding to occurrences of retaliation against whistleblowers.
DEPARTMENT OF HEALTH AND HUMAN SERVICES : Health and Human Services Department

11. White House Commission on Complementary and Alternative Medicine Policy; Notice of Meeting

NOTICES: Complementary and Alternative Medicine Policy, White House Commission,

Pursuant to Section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is given of a meeting of the White House Commission on Complementary and Alternative Medicine Policy.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Health and Human Services Department

12. Findings of Scientific Misconduct

NOTICES: Dreyer, Evan B., M.D., Ph.D.,

Notice is hereby given that the Office of Research Integrity (ORI) and the Assistant Secretary for Health have taken final action in the following case:

Evan B. Dreyer, M.D., Ph.D., Massachusetts Eye and Ear Infirmary (MEEI) and Harvard Medical School (HMS): Based on the findings and evidence documented in a report by a joint inquiry panel,

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Health and Human Services Department

14. Advisory Committee; Notice of Meeting

NOTICES: Training in Primary Care Medicine and Dentistry Advisory Committee,

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Public Law 92463), announcement is made of the following National Advisory body scheduled to meet during the month of December 2000.

Name: Advisory Committee on Training in Primary Care Medicine and Dentistry.

Date and Time: December 7, 2000, 8 a.m.5 p.m.;

DEPARTMENT OF HEALTH AND HUMAN SERVICES : Health Resources and Services Administration

15. Office of the Director; Notice of Meeting

NOTICES: Advisory Committee to the Director,

Pursuant to Pub. Law 92463, notice is hereby given of a meeting of the Advisory Committee to the Director, NIH.

The entire meeting will be open to the public as indicated below,with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

16. National Cancer Institute; Notice of Meeting

NOTICES: National Cancer Institute,

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of the National Cancer Advisory Board.

The meeting will open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

17. National Cancer Institute; Notice of Closed Meetings

NOTICES: National Cancer Institute,

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

18. National Cancer Institute; Notice of Closed Meeting

NOTICES: National Cancer Institute,

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

19. National Cancer Institute; Notice of Closed Meeting

NOTICES: National Cancer Institute,

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

20. National Cancer Institute; Notice of Closed Meeting

NOTICES: National Cancer Institute,

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

21. National Center for Research Resources; Notice of Closed Meeting

NOTICES: National Center for Research Resources,

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

22. National Eye Institute; Notice of Closed Meeting

NOTICES: National Eye Institute,

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

23. National Institute of Allergy and Infectious Diseases; Notice of Meetings

NOTICES: National Institute of Allergy and Infectious Diseases,

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of meetings of the National Advisory Allergy and Infectious Diseases Council.

The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

24. National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting

NOTICES: National Institute of Arthritis and Musculoskeletal and Skin Diseases,

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the Board of Scientific Counselors, NIAMS.

The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

25. National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

NOTICES: National Institute of Diabetes and Digestive and Kidney Diseases,

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C. as amended. The grant applications and the

DEPARTMENT OF HEALTH AND HUMAN SERVICES : National Institutes of Health

©2004,2005,2006 theFederalRegister.com